Cordycepin, which is a nucleoside derivative isolated from Cordyceps, inhibits IL-1β-induced MMP-1 and MMP-3 expression in rheumatoid arthritis synovial fibroblasts (RASFs) in a dose-dependent manner.
Parameter
Value
Chemical Name
Cordycepin
CAS No.
73-03-0
Synonyms
Cordycepin;3'-DEOXYADENOSINE;3’-deoxy-adenosin;9-cordyceposidoadenine;cordycepin crystalline;9-(3-Deoxy-b-D-erythro-pentofuranosyl)-9H-purin-6-amine;9-(3-Deoxy-b-D-ribofuranosyl)adenine;Cordycepin from Cordyceps militaris;CORDYCEPIN(RG);(-)-cordycepin;3'-Deoxy-D-adenosine;Adenine cordyceposide;Adenosine,3-deoxy;Cordycepin Hydrate;Cordyceps fungus powder;3'-Deoxyadenosine from Cordyceps militaris;3′-Deoxyadenosine;Cordycepine;ADENOSINE, 3'-DEOXY-;9-(beta-D-3'-Deoxyribofuranosyl)adenine;9H-Purine, 6-amino-9-(3-deoxy-beta-D-ribofuranosyl)-;GZ8VF4M2J8;OFEZSBMBBKLLBJ-BAJZRUMYSA-N;beta-D-erythro-Pentofuranoside, adenine-9 3-deoxy-;9H-Purin-6-amine, 9-(3-deoxy-beta-D-erythro-pentofuranosyl)-;(2R,3R,5S)-2-(6-amino-9H-purin-9-yl)-5-(hydroxy
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Biological Activity
Cordycepin, which is a nucleoside derivative isolated from Cordyceps, inhibits IL-1β-induced MMP-1 and MMP-3 expression in rheumatoid arthritis synovial fibroblasts (RASFs) in a dose-dependent manner.
In Vitro
Cordycepin is a potent inhibitor of IL-1β-induced chemokine production and MMP expression and strongly blocks the p38/JNK/AP-1 signalling pathway in RASFs. The effect of Cordycepin on cellular toxicity of RASFs is assessed using MTT assay. Treatment of RASFs with Cordycepin (50 μM or 100 μM) for 24 h does not cause any significant change in cell viability. However, cell viability is slightly decreased when cells are incubated with 100 μM Cordycepin for 48 h[1].
In Vivo
No in vivo data are provided in the current product source. Contact us for further information.
Published experimental findings depend on the model and assay conditions. They do not guarantee equivalent performance in every application. For laboratory research use only.
Fluzoparib (SHR-3162) is a novel, potent and orally available inhibitor of PARP; potently inhibited PARP1 enzyme activity and induced DNA double-strand breaks, G2/M arrest and apoptosis in homologous recombination…
PBIT is a specific inhibitor of the Jumonji AT-rich Interactive Domain 1(JARID1) enzymes. PBIT inhibits JARID1B (KDM5B or PLU1 ) histone demethylase an IC50 of about 3 μM . PBIT also inhibits JARID1A and JARID1C with…
AWD 131-138(Imepitoin) is a new low-affinity partial benzodiazepine receptor agonist with potent anticonvulsant and anxiolytic properties in rodent models.
Merestinib dihydrochloride (LY2801653 dihydrochloride) is a type-II ATP competitive, slow-off inhibitor of MET tyrosine kinase with a dissociation constant (Ki) of 2 nM.
Fenoldopam(SKF 82526) mesylate is a drug and synthetic benzazepine derivative which acts as a selective D1 receptor partial agonist.Target: D1 ReceptorFenoldopam is a selective dopamine-1 (DA1) agonist with…
